Exemplis Discimus 2012, 156(2):103-107

Mauris ligula eros, condimentum vel, malesuada ac, sollicitudin in, urna.

Lisa Magnusa, Deel Shomab, Azalyn Rowanb
a Department of Child psychiatry, Hypori Teaching Hospital, Republic of Ord Mantell
b Clinic of Psychiatric Nursing, Kamino University, Taanab Republic

Background: Aliquam sodales, lectus id pharetra tempor, eros justo tempus lectus, sit amet ornare nibh erat et mauris. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos.

Methods: In dapibus, lorem eget bibendum gravida, elit enim aliquam nunc, a elementum quam lorem vel mi. Vivamus pellentesque, est eu adipiscing gravida, sem nisi rhoncus justo, id vehicula arcu mi nec ligula.

Results: Fusce aliquam, lectus pellentesque sollicitudin laoreet, leo dolor imperdiet libero, eu tristique dolor tortor in quam. Fusce aliquam, lectus pellentesque sollicitudin laoreet, leo dolor imperdiet libero, eu tristique dolor tortor in quam.

Conclusions: Proin ligula lacus, sollicitudin in, euismod quis, elementum vitae, turpis. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Donec nec eros id tortor scelerisque rutrum. Curabitur ut dolor vel nunc lacinia volutpat. Suspendisse pede lectus, iaculis id, pharetra et, porta non, leo. Duis non risus at quam fermentum scelerisque. Mauris felis neque, pellentesque eu, placerat in, pharetra eu, odio. Suspendisse a ipsum vel eros iaculis euismod.

Kľúčové slová: Sed eget nisl

Vložený: August 22, 2011; Přijatý: February 21, 2012; Uverejnené online: May 10, 2012; Uverejnené: June 1, 2012 

Zobraziť celý článok

Referencie

  1. Hricak H, Choyk PL, Eberhardt S, Leibel SA,Scardino PT. Imaging prostate cancer: a multidisciplinary perspective. Radiology 2007;243:28- 53. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  2. Wang L. Incremental value of magnetic resonance imaging in the advanced management of prostate cancer. World J Radiol 2009;31:3- 14. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  3. Kattan MW, Scardino PT. Prediction of progression: nomograms of clinical utility. Clin Prostate Cancer 2002;1:90-6. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  4. Claus FG, Hricak H, Hattery RR. Pretreatment evaluation of prostate cancer: role of MR imaging and 1 H MR spectroscopy. Radiographics 2004;24:Suppl1:16780. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  5. Giusti S, Caramella D, Fruzzetti E, Lazzereschi M, Tognetti A, Bartolozzi C. Peripheral zone prostate cancer. Pre-treatment evaluation with MRI and 3D (1)H MR spectroscopy imaging: correlation with pathologic findings. Abdom Imaging 2010; 35:757-63. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  6. Wang L, Van den Bos IC, Hussain SM, Pattynama PM, Vogel MW, Krestin GP. Post-processing of dynamic gadolinium-enhanced magnetic resonance imaging exams of the liver:explanation and potential clinical applications for colour-coded qualitative and quantitative analysis. Acta Radiol 2008;49:6-18. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  7. Wang L, Mullerad M, Chen HN, Eberhardt SC, Kattan MW, Scardino PT, Hricak H. Prostate cancer: incremental value of endorectal MR findings for prediction of extracapsular extension. Radiology 2004;232:133-9. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  8. Futterer JJ, Engelbrecht RM, Jafer JG,Hartman RP, King BF, Hulsbergen-Van de Kaa CA, Witjes JA,Barentsz JO. Prostate cancer: comparison of local staging accuracy of pelvic phased - array coil versus integrated endorectal-pelvic phased-array coils. Eur Radiol 2007;17:1055-65. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  9. Park BK, Kim B, KimCK, Lee HM, Kwon GY. Comparison of Phasedarray 3.0T and endorectal 1.5T magnetic resonance imaging in the evaluation of local staging accuracy for prostate cancer. Comput Assist Tomogr 2007;31(4):534-8. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  10. Kim B, Breau RH, Papadatos D, Fergusson D, Doucette S, Cagiannos I, Morash C. Diagnostic accuracy of surface coil magnetic resonance imaging at 1.5T for local staging of elevated risk prostate cancer. Can Urol Assoc J 2010;4:257-62. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  11. Augustin H, Fritz GA, Ehammer T, Auprich M,Pummer K. Accuracy of 3-Tesla magnetic resonance imaging for the staging of prostate cancer in comparison to the Partin tables. Acta Radiol 2009;50:562-9. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  12. Verma S, Rajesh A, Morales H, Lemen L,Bills G,Delworth M, Gaitonde K,Yinq J,Samartunga R, Lamba M. Assessment of aggressiveness of prostate cancer: correlation of apparent diffusion coefficient with histologic grade after radical prostatectomy. AJR Am J Roentgenol 2011;196:374-81. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  13. Iwazawa J, Mitani T, Sassa S, Shoichi O. Prostate cancer detection with MRI:is dynamic contrast-enhanced imaging necessary in addition to diffusion-weighted imaging? Diagn Interv Radiol. DOI 10.4261/1305-3825.DIR3605-10.1.
  14. Panebianco V, Sciarra A, Lisi D, Galati F, Buoconore V, Catalano C, Gentile V, Laghi A, Passariello R. Prostate cancer:1HMRS-DCEMR at 3T versus [(18)] choline PET/CT in the detection of local prostate cancer recurrence in men with biochemical progression after radical retropubic prostatectomy (RRP). Eur J Radiol Feb 2011 [Epub ahead of print] http://dx.doi.org/10.1016/j.ejrad.2011.01.095.
  15. Mazaheri Y, Hricak H, Fine SW, Akin O, Shukla-Dave A, Ishill NM, Moskowitz CS,Grater JE,Reuter VE, Zakian KL, Touijer KA, Koutcher JA. Prostate tumor volume measurement with combined T2- weighted imaging and diffusion-weighted MR: correlation with pathologic tumor volume. Radiology 2009;25:449-57. DOI:10.1148/ radiol.2523081423. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  16. Nakashima J,Tanimoto A, Imai Y, Mukai M, Horiguchi Y, Nakagawa K, Oya H, Ohigashi T, Marumo K, Murai M. Endorectal MRI for prediction of tumor site, tumor size, and local extension of prostate cancer. Urology 2004;64:101-5. DOI:10.1016/j.urology.2004.02.036. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  17. Lawrentschuk N, Lindner U. Recent advances in magnetic resonance imaging of prostate cancer. F1000 Med Rep 2010;2:86. DOI:10.3410/ M2-86. Prejsť na PubMed...
  18. Chopra R, Tang K, Butnyk M, Boyes A, Sugar L, Appu S, Klotz L, Bronskill M. Analysis of the spatial and temporal accuracy of heating in the prostate gland using transurethral ultrasound therapy and active MR temperature feedback. Phys Med Biol 2009;54:2615-33. DOI:10.1088/0031-9155/54/9/002. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  19. Rouvierer O, Girouin N, Glas L, Ben Cheikh A, Gelet A, Mége - Lechevallier F, Rabilloud M, Chapelon JY, Lyonnet D. Prostate cancer transrectal HIFU ablation: detection of local recurrences using T2-weighted and dynamic contrast-enhanced MRI. Eur Radiol 2010;20:48-55. DOI 10.1007/s00330-009-1520-5. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  20. Harisinghani MG, Barentz JO, Hahn PF, Deserno WM, Tabataei S, van de KAA CH, de la Rossete J, Weissleder R. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 2003;348:2491-9. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  21. Naughton CK, Ornstein DK, Smith DS, Catalona WJ. Pain and morbidity of transrectal ultrasound guided prostate biopsy: a prospective randomized trial of 6 versus 12 cores. J Urol 2000;163:168-71. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  22. Cheikh AB, Girouin N, Colombel M, Maréchal JM, Gelet A, Bissery A, Rabilloud M, Lyonnet D, Rouviére O. Evaluation of T2-weighted and dynamic contrast- enhanced MRI in localizing prostate cancer before repeat biopsy. Eur Radiol 2009;19:770-8. DOI: 10.1007/s00330-008- 1190-8. Prejsť k pôvodnému zdroju... Prejsť na PubMed...

Späť na obsah